PCRX Pacira Pharmaceuticals Inc/DE

Ownership history in MassMutual Private Wealth & Trust, FSB  ·  21 quarters on record

AI Ownership Summary

MassMutual Private Wealth & Trust, FSB reported Pacira Pharmaceuticals Inc/DE (PCRX) in 21 quarterly 13F filings from 2023 Q4 through 2026 Q1. The latest visible filing shows PCRX at 0.00% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this PCRX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was MassMutual Private Wealth & Trust, FSB's position in Pacira Pharmaceuticals Inc/DE, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q1

PCRX was reported at 0.00% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.0% in 2023 Q4

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2023 Q4 to 2026 Q1

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How MassMutual Private Wealth & Trust, FSB held PCRX — position size vs. price
% of Fund (quarterly)    PCRX price (quarter-end, indexed to 100)
📋 Quarterly Holdings History 10 quarters  
Quarter Action Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q1 ADDED 335 +24 +7.7% 0.00% $8K 2026-04-13 $24.06
2025 Q4 ADDED 311 +28 +9.9% 0.00% $8K 2026-01-07 $26.00
2025 Q3 REDUCED 283 -118 -29.4% 0.00% $7K 2025-10-22 $21.49
2025 Q2 ADDED 401 +68 +20.4% 0.00% $10K 2025-07-09 $23.17
2025 Q1 ADDED 333 +288 +640.0% 0.00% $8K 2025-04-01 $24.07
2024 Q4 UNCHANGED 45 0% 0.00% $848 2025-01-16 $22.06
2024 Q3 REDUCED 45 -165 -78.6% 0.00% $677 2024-10-02 $15.53
2024 Q2 REDUCED 210 -93 -30.7% 0.00% $6K 2024-07-02 $22.74
2024 Q1 ADDED 303 +15 +5.2% 0.00% $9K 2024-04-09 $28.52
2023 Q4 ADDED 288 +254 +747.1% 0.00% $10K 2024-01-03 $32.07
11 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

FAQ About MassMutual Private Wealth & Trust, FSB and PCRX

These are the practical questions this page is built to answer before you even open the full history table.

How long has MassMutual Private Wealth & Trust, FSB reported owning PCRX?

MassMutual Private Wealth & Trust, FSB reported PCRX across 10 quarterly 13F filings, from 2023 Q4 through 2026 Q1.

What was the largest reported PCRX position in MassMutual Private Wealth & Trust, FSB's portfolio?

The largest reported portfolio weight for PCRX was 0.00% in 2023 Q4.

What is the latest reported PCRX position on this page?

The most recent filing on this page is 2026 Q1, when MassMutual Private Wealth & Trust, FSB reported 335 shares, equal to 0.00% of portfolio, with an estimated market value of $8K.

What does the chart on this PCRX ownership page compare?

The chart compares MassMutual Private Wealth & Trust, FSB's quarterly PCRX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to MassMutual Private Wealth & Trust, FSB Holdings